Based in Bethlehem, Pennsylvania, OraSure Technologies develops, manufactures and markets point-of-care, oral fluid specimen collection devices that leverage proprietary oral fluid technologies, diagnostic products, including immunoassays and other in vitro diagnostic tests, and other medical devices.
These products include tests for the detection of antibodies for the HIV virus, including OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test and the OraSure® HIV-1 Oral Specimen Collection Device, and oral fluid testing solutions for drugs of abuse testing, including Intercept® Oral Fluid Drug Testing System and Q.E.D.® Saliva Alcohol Test.
These products are sold in the United States, as well as internationally, to various clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities.
The Company also manufactures and sells several leading cryosurgical products. These include: Histofreezer®, a medical professional product for the cryosurgical removal of common, flat and plantar warts, and other benign skin lesions, sold to the professional or physician office market in the United States and many foreign countries. The Company also manufactures and sells an over-the-counter product for the cryosurgical removal of common and plantar warts, available in the United States, Canada, Mexico, certain European countries, Australia and New Zealand.
Company Growth (employees)
OraSure Technologies was founded in 1987 and is headquartered in Bethlehem, US
OraSure Technologies Office Locations
OraSure Technologies has an office in Bethlehem
Bethlehem, US (HQ)
220 E 1st St
Bethlehem, US
1745 Eaton Ave
Bethlehem, US
150 Webster St
OraSure Technologies Data and Metrics
OraSure Technologies Financial Metrics
OraSure Technologies's revenue was reported to be $32.5 m in Q1, 2017
USD
Revenue (Q1, 2017) | 32.5 m |
Gross profit (Q1, 2017) | 20.3 m |
Gross profit margin (Q1, 2017), % | 62% |
Net income (Q1, 2017) | 12.4 m |
EBIT (Q1, 2017) | 15.9 m |
Market capitalization (25-Jul-2017) | 1.1 b |
Cash (31-Mar-2017) | 120.9 m |
OraSure Technologies's current market capitalization is $1.1 b.
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 98.9 m | 106.5 m | 119.7 m | 128.2 m |
Revenue growth, % | 13% | 8% | 12% | 7% |
Cost of goods sold | 40.4 m | 39.8 m | 39.4 m | 40.2 m |
Gross profit | 58.6 m | 66.6 m | 80.3 m | 88 m |
Gross profit Margin, % | 59% | 63% | 67% | 69% |
Sales and marketing expense | 29.7 m | |||
R&D expense | 9.8 m | |||
General and administrative expense | 28.4 m | |||
Operating expense total | 70.8 m | 71.4 m | 72.2 m | 67.8 m |
EBIT | (12.2 m) | (4.8 m) | 8.1 m | 20.3 m |
EBIT margin, % | (12%) | (5%) | 7% | 16% |
Pre tax profit | (12 m) | (4.3 m) | 8.8 m | 20.3 m |
Income tax expense | (772 k) | 343 k | 665 k | 603 k |
Net Income | (11.2 m) | (4.6 m) | 8.2 m | 19.7 m |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.4 m | 27.8 m | 27.1 m | 30.4 m | 29.9 m | 29.1 m | 31.4 m | 32.3 m | 32.5 m |
Cost of goods sold | 10.4 m | 9.1 m | 10.1 m | 9.7 m | 9.2 m | 8.8 m | 10.3 m | 9.6 m | 12.2 m |
Gross profit | 16 m | 18.7 m | 17 m | 20.7 m | 20.7 m | 20.3 m | 21.1 m | 22.7 m | 20.3 m |
Gross profit Margin, % | 61% | 67% | 63% | 68% | 69% | 70% | 67% | 70% | 62% |
Sales and marketing expense | 10.3 m | 9.2 m | 7.9 m | 8.9 m | 9.7 m | 8.7 m | 7.4 m | 6.4 m | 6.9 m |
R&D expense | 2.8 m | 3 m | 3.4 m | 3 m | 2.5 m | 2.4 m | 3 m | 3.2 m | 3 m |
General and administrative expense | 6 m | 5.6 m | 6 m | 6.1 m | 6.9 m | 6.5 m | 6.4 m | 6.9 m | 7.1 m |
Operating expense total | 19 m | 17.8 m | 17.3 m | 18 m | 19.1 m | 17.6 m | 16.7 m | 16.5 m | 16.9 m |
EBIT | 2.5 m | 882 k | (291 k) | 2.7 m | 1.5 m | 2.7 m | 4.3 m | 6.1 m | 15.9 m |
EBIT margin, % | 9% | 3% | (1%) | 9% | 5% | 9% | 14% | 19% | 49% |
Pre tax profit | 2.4 m | 1.2 m | 118 k | 2.6 m | 1.6 m | 2.5 m | 4 m | 6.6 m | 16.3 m |
Income tax expense | (174 k) | 10 k | 5 k | 658 k | 147 k | 61 k | 173 k | 400 k | 3.9 m |
Net Income | (3.1 m) | (2 m) | 113 k | 2.1 m | 3.6 m | 2.4 m | 6.3 m | 12.5 m | 12.4 m |
- Source: SEC Filings
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 93.2 m | 92.9 m | 94.1 m | 108 m |
Inventories | 11.4 m | 15.8 m | 13.2 m | 11.8 m |
Current Assets | 119.6 m | 131.2 m | 136.7 m | 156.4 m |
PP&E | 17.9 m | 17.9 m | 20.1 m | 20 m |
Goodwill | 23.8 m | 21.7 m | 18.3 m | 18.8 m |
Total Assets | 184.2 m | 189.6 m | 189.3 m | 207.9 m |
Accounts Payable | 4.8 m | 7.1 m | 5.1 m | 4.6 m |
Current Liabilities | 19 m | 26.5 m | 25.2 m | 17.3 m |
Additional Paid-in Capital | 338.7 m | 344.9 m | 345.3 m | 350.5 m |
Retained Earnings | (173.7 m) | (178.3 m) | (170.2 m) | (150.5 m) |
Total Equity | 161.1 m | 158.7 m | 159.4 m | 185.9 m |
Financial Leverage | 1.1 x | 1.2 x | 1.2 x | 1.1 x |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Cash | 75.8 m | 93.9 m | 85.5 m | 83.4 m | 100.7 m | 94.6 m | 105.7 m | 111.7 m | 120.9 m |
Inventories | 13.2 m | 14.8 m | 15.6 m | 15.7 m | 15 m | 12.3 m | 11.4 m | 12.1 m | 12.7 m |
Current Assets | 115.8 m | 130 m | 123.2 m | 125.3 m | 141.8 m | 134.3 m | 146.4 m | 150.7 m | 180.5 m |
PP&E | 18.5 m | 18 m | 17.6 m | 17.9 m | 17.8 m | 20.2 m | 20.2 m | 20.1 m | 20.1 m |
Goodwill | 23.7 m | 22.6 m | 19.9 m | 20.2 m | 19 m | 19.4 m | 19.5 m | 19.2 m | 19 m |
Total Assets | 179.6 m | 190.5 m | 177.6 m | 180.1 m | 193.8 m | 188.5 m | 199.9 m | 203.6 m | 232.6 m |
Accounts Payable | 4.6 m | 4.5 m | 5 m | 4.7 m | 7 m | 5.3 m | 4 m | 4.4 m | 7.3 m |
Current Liabilities | 14.7 m | 25.3 m | 17.5 m | 15.6 m | 29.7 m | 20.3 m | 26.1 m | 22 m | 18.3 m |
Additional Paid-in Capital | 341.1 m | 342.9 m | 345.7 m | 347.1 m | 348.7 m | 343.5 m | 345.1 m | 347.3 m | 360.6 m |
Retained Earnings | (176.8 m) | (175.7 m) | (178.2 m) | (176.3 m) | (174.8 m) | (167.7 m) | (163.9 m) | (157.7 m) | (138 m) |
Total Equity | 160.3 m | 160.9 m | 155.8 m | 159.9 m | 160 m | 163 m | 168.8 m | 176.5 m | 208.8 m |
Financial Leverage | 1.1 x | 1.2 x | 1.1 x | 1.1 x | 1.2 x | 1.2 x | 1.2 x | 1.2 x | 1.1 x |
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | (11.2 m) | (4.6 m) | 8.2 m | 19.7 m |
Depreciation and Amortization | 6.6 m | 6.3 m | 5.7 m | 5.7 m |
Accounts Receivable | 4.3 m | (3.4 m) | (3.7 m) | (576 k) |
Inventories | 1.3 m | (4.4 m) | 2.3 m | 1.5 m |
Accounts Payable | 1.5 m | 2.2 m | (2.6 m) | 46 k |
Cash From Operating Activities | 8.4 m | 7.5 m | 15.8 m | 22.8 m |
Purchases of PP&E | (2.5 m) | (3 m) | (3.7 m) | (4.4 m) |
Cash From Investing Activities | (2.5 m) | (8 m) | (6.7 m) | (8.1 m) |
Cash From Financing Activities | (420 k) | 476 k | (5.7 m) | (1.2 m) |
| USD | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | (3.1 m) | (2 m) | 113 k | 2.1 m | 3.6 m | 2.4 m | 6.3 m | 12.5 m | 12.4 m |
Depreciation and Amortization | 3.1 m | 4.7 m | 1.4 m | 2.8 m | 4.3 m | 1.4 m | 2.8 m | 4.2 m | 1.4 m |
Accounts Receivable | (1.2 m) | (2.1 m) | (552 k) | (524 k) | (1.6 m) | 2.5 m | 893 k | 3.8 m | (4.1 m) |
Inventories | (1.8 m) | (3.4 m) | 57 k | 35 k | 633 k | 990 k | 1.9 m | 1.2 m | (893 k) |
Accounts Payable | (179 k) | (284 k) | (2.1 m) | (2.5 m) | (72 k) | 758 k | (782 k) | (125 k) | 2.6 m |
Cash From Operating Activities | (10.4 m) | 8.4 m | (6.6 m) | (3.4 m) | 15.1 m | 4.7 m | 16.7 m | 23.4 m | 12.6 m |
Purchases of PP&E | (2 m) | (2.4 m) | (437 k) | (1.1 m) | (1.9 m) | (1.6 m) | (2.7 m) | (3.5 m) | (878 k) |
Cash From Investing Activities | (6.4 m) | (7.3 m) | 602 k | (4.1 m) | (4.8 m) | (1.6 m) | (2.7 m) | (3.5 m) | (8.4 m) |
Cash From Financing Activities | (437 k) | (93 k) | (651 k) | (759 k) | (759 k) | (3.2 m) | (3.1 m) | (2.8 m) | 8.6 m |
Income Taxes Paid | 42 k | 42 k | 81 k | 81 k | 230 k | 84 k | 556 k | 812 k | 1.9 m |
| USD | Y, 2017 |
|---|---|
Revenue/Employee | 100.1 k |
Financial Leverage | 1.1 x |
OraSure Technologies Operating Metrics
OraSure Technologies's Facilities was reported to be 2 in FY, 2016
